HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

MitoSciences awarded $590,000 to support development of companion diagnostic tests for antiviral drugs

MitoSciences announces that it has just been awarded $590,000 by the National Institutes of Health to support the development of companion diagnostic tests for antiviral drugs. The award was made after competitive scientific review and was issued under The American Recovery and Reinvestment Act of 2009.

14 May 2010

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 May 2010

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.

14 May 2010

Genetic Immunity formulates first topically administered nanomedicine therapeutic vaccine for HIV/AIDS

Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.

13 May 2010

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

In 1985 there was little hope for people with AIDS. Newspapers and television screens were filled with ghastly pictures of emaciated figures dying from a disease that had no cure.

13 May 2010

AHF targets BMS over pricing and policies for its HIV/AIDS drug

AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.

13 May 2010

U.S. expands HIV/AIDS programs in Caribbean

Representatives from the U.S. and Caribbean Community (CARICOM) on Tuesday signed an agreement to expand PEPFAR programs to 12 other Caribbean nations during a gathering in Georgetown, Guyana, Agence France-Presse reports (5/11).

13 May 2010

HIV caseload increasing among primary care providers

Primary care providers (PCPs) are increasingly caring for and treating people living with HIV, according to the HealthHIV State of HIV Primary Care survey released today.

12 May 2010

Avexa halts HIV drug trials

Melbourne-based biotech Avexa has announced the closure of its lead HIV program for apricitabine after failing to attract a licensing partner for the Phase III drug.

12 May 2010

Merck hosts R&D and Business Briefing

Merck & Co., Inc. today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger. The event included a comprehensive review of the company's late-stage pipeline, as well as the company's commercial strategy and progress made in the integration of Merck's worldwide operations.

12 May 2010

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.

12 May 2010

MRSA Survivors Network to raise awareness on MRSA infections

More Americans die annually from invasive methicillin-resistant Staphylococcus aureus infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis.

12 May 2010

Gilead Sciences board authorizes $5 billion common stock repurchase program

Gilead Sciences, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.

12 May 2010

U.S., Haitian partners meet to discuss elections as Haitian parliamentary terms expire

In an article examining elections in Haiti and their impact on the country's recovery from the January 12 earthquake, the Miami Herald writes that Canada, the U.S., the Organization of American States, the U.N. and other partners have "dispatched top lieutenants [to Port-au-Prince] for a Monday meeting" with President Rene Preval to discuss elections.

11 May 2010

Global efforts to combat HIV and AIDS confront changes as funding priorities shift

The New York Times detailed the current funding challenges facing the global effort to combat HIV and AIDS, using the country of Uganda as an example. "Uganda is the first and most obvious example of how the war on global AIDS is falling apart." Although this nation has made significant advances in what "some doctors call a 'golden window' for treatment," clinics are now routinely turning people away.

11 May 2010

Improving newborn care in first month of life essential for reducing child mortality

Improving newborn care in the first month of life is essential for reducing child deaths in developing countries, according to a global update on the Millennium Development Goals (MDGs) released today in the World Health Statistics 2010.

11 May 2010

'Striking improvements' toward MDG targets, progress is unequal, WHO report says

The WHO's annual health statistics report, released Monday, found that global efforts aimed at achieving Millennium Development Goal (MDG) targets have led to "striking improvements" among goals related to child health, maternal mortality, malaria and HIV/AIDS, Reuters reports.

11 May 2010

New York Times examines global fight against HIV/AIDS

Several articles in the New York Times examine the global fight against HIV/AIDS. "Uganda is the first country where major clinics routinely turn people away" because they lack funding, the newspaper writes in an article that reports "money for [HIV/AIDS] treatment has stopped growing."

11 May 2010

Lancet examines Canada's G8 strategy for maternal, child health initiatives

A Lancet World Report examines the details of the Canadian government's strategy for the G8 maternal and child health initiative and reactions from global health leaders and politicians to the plan, including the announcement during a meeting of G8 leaders Halifax, Nova Scotia, that the initiative would not support abortion.

10 May 2010

Women's empowerment, regional integration, malaria prevention discussed at WEF on Africa

On the second day of the World Economic Forum (WEF) on Africa, Graca Machel, founder and president of the Foundation for Community Development, called on African governments to implement strategies aimed at empowering women in order to accelerate the continent's social and economic development, Tanzania Daily News/allAfrica.com reports.

10 May 2010

HIV/AIDS News and Research

Further Reading

MitoSciences awarded $590,000 to support development of companion diagnostic tests for antiviral drugs

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

Chimerix commences first-in-human study of CMX157 for HIV

Genetic Immunity formulates first topically administered nanomedicine therapeutic vaccine for HIV/AIDS

Celera to present on AIDS pandemic, AZT drugs at Computational Molecular Biology Symposium

AHF targets BMS over pricing and policies for its HIV/AIDS drug

U.S. expands HIV/AIDS programs in Caribbean

HIV caseload increasing among primary care providers

Avexa halts HIV drug trials

Merck hosts R&D and Business Briefing

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

MRSA Survivors Network to raise awareness on MRSA infections

Gilead Sciences board authorizes $5 billion common stock repurchase program

U.S., Haitian partners meet to discuss elections as Haitian parliamentary terms expire

Global efforts to combat HIV and AIDS confront changes as funding priorities shift

Improving newborn care in first month of life essential for reducing child mortality

'Striking improvements' toward MDG targets, progress is unequal, WHO report says

New York Times examines global fight against HIV/AIDS

Lancet examines Canada's G8 strategy for maternal, child health initiatives

Women's empowerment, regional integration, malaria prevention discussed at WEF on Africa

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News